Duffy D M, diZerega G S
Livingston Reproductive Biology Laboratories, Department of Obstetrics and Gynecology, School of Medicine, University of Southern California, Los Angeles, USA.
J Reprod Med. 1996 Jan;41(1):19-26.
To review the clinical data that specifically address the contribution of pelvic adhesive disease to pelvic pain and the use of intraperitoneal crystalloid instillants in the prevention of postoperative pelvic adhesions.
A review of contemporary reports that describe relevant clinical studies.
The data on adhesions and pelvic pain suggest that adhesions can cause pelvic pain and that adhesiolysis relieves pain in 60-90% of cases. Adhesions in patients with pelvic pain are associated with restricted motion or expansibility of organs, whereas adhesions in patients without pain usually cause no such restriction. Even though hydroflotation may appear to be effective at very early postoperative intervals, the process of peritoneal repair, fibrin deposition and adhesion formation extends well beyond the time of crystalloid absorption.
Laparoscopy is appropriate in patients with pelvic pain. Adhesions found in those patients, especially involving the adnexa, should be removed. Clinical evidence does not support the use of crystalloids in adhesion prevention.
回顾专门探讨盆腔粘连性疾病对盆腔疼痛的影响以及腹腔内注入晶体溶液预防术后盆腔粘连的临床数据。
对描述相关临床研究的当代报告进行综述。
关于粘连与盆腔疼痛的数据表明,粘连可导致盆腔疼痛,而粘连松解术能在60%至90%的病例中缓解疼痛。盆腔疼痛患者的粘连与器官活动受限或扩张性受限有关,而无疼痛患者的粘连通常不会导致此类限制。尽管在术后极早期进行液体冲洗似乎有效,但腹膜修复、纤维蛋白沉积和粘连形成的过程远远超出晶体吸收的时间。
腹腔镜检查适用于盆腔疼痛患者。在这些患者中发现的粘连,尤其是涉及附件的粘连,应予以清除。临床证据不支持使用晶体溶液预防粘连。